



Healthcare | Small Cap
Krishna Institute of Medical Sciences Ltd demonstrates a mixed financial performance. The company exhibits strong growth in revenue, operating profit, and assets. Its ability to cover interest expenses is also robust. Profitability is a notable strength, driven by healthy gross profit and operating margins, as well as a good return on assets. However, the company shows zero figures across liquidity metrics which raises concerns. The company maintains a strong equity position but also has zero debt. While the company shows growth, the net income growth rate is zero. The company's efficiency in utilizing fixed assets and capital appears to be low given the low turnover ratios. The healthcare industry is subject to regulatory changes and economic conditions, influencing operational strategies and financial results.
Krishna Institute of Medical Sciences Ltd demonstrates a mixed financial performance. The company exhibits strong growth in revenue, operating profit, and assets. Its ability to cover interest expenses is also robust. Profitability is a notable strength, driven by healthy gross profit and operating margins, as well as a good return on assets. However, the company shows zero figures across liquidity metrics which raises concerns. The company maintains a strong equity position but also has zero debt. While the company shows growth, the net income growth rate is zero. The company's efficiency in utilizing fixed assets and capital appears to be low given the low turnover ratios. The healthcare industry is subject to regulatory changes and economic conditions, influencing operational strategies and financial results.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
116.32
Industry Median
53.17
Small Cap Median
50.07
P/E RATIO
125.77
P/B RATIO
13.49
Industry Median
5.27
Small Cap Median
3.62
P/S RATIO
7.58
Industry Median
3.91
Small Cap Median
2.08
Others
PEG RATIO
0.00
EV/EBITDA RATIO
40.55
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹758.4 as on Sep 1, 2026.
The company demonstrates strong growth in revenue, operating profit, earnings per share, and assets. This indicates successful expansion and effective management strategies. While the company shows growth, the net income growth rate is zero. Sustaining this growth trajectory will depend on continued innovation and effective capital management.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 24.14 | 33.13 | 13.65 | 21.5 | 28.67 |
| Operating Profit Growth Rate | 38.99 | 16.6 | 6.06 | 22.38 | 1.13 |
| Earnings Per Share (EPS) Growth | 60.31 | 1.08 | -7.85 | 24 | -37.25 |
| Asset Growth Rate | 32.87 | 52.36 | 31.68 | 48.93 | 36.39 |
| Net Income Growth Rate | 67.8 | 6.4 | -8.2 | 23.51 | -41.69 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Krishna Institute of Medical Sciences Ltd (KIMS) is one of the largest corporate healthcare groups in South India, operating a chain of multi-specialty hospitals. It provides comprehensive healthcare services, including advanced medical, surgical, and diagnostic treatments, primarily across Andhra Pradesh and Telangana, focusing on affordable quality care and clinical excellence.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Krishna Institute of Medical Sciences Ltd's P/E ratio (TTM) is 116.32, compared to the industry median of 53.17 and large cap median of 50.07.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Krishna Institute of Medical Sciences Ltd's P/B ratio is 13.49, compared to the industry median of 5.27 and large cap median of 3.62.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Krishna Institute of Medical Sciences Ltd's P/S ratio is 7.58, compared to the industry median of 3.91 and large cap median of 2.08.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Krishna Institute of Medical Sciences Ltd's PEG ratio is 1.90.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Krishna Institute of Medical Sciences Ltd's EV/EBITDA ratio is 40.55.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Krishna Institute of Medical Sciences Ltd's ROE is 10.77%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Krishna Institute of Medical Sciences Ltd's ROA is 10.34%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Krishna Institute of Medical Sciences Ltd's ROCE is 9%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Krishna Institute of Medical Sciences Ltd's operating margin is 20.54%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Krishna Institute of Medical Sciences Ltd's net margin is 6.20%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Krishna Institute of Medical Sciences Ltd's current ratio is 0.73.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Krishna Institute of Medical Sciences Ltd's debt-to-equity ratio is 1.63.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Krishna Institute of Medical Sciences Ltd's interest coverage ratio is 2.65.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Krishna Institute of Medical Sciences Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Krishna Institute of Medical Sciences Ltd's EPS is -37.25.
(Source line: "Ratios as of 01 Sept 2026, based on last traded price of ₹758.40. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2000 (though the first hospital was established in 1982)
Headquarters: Secunderabad, Telangana
Core Offerings: Multi-specialty inpatient services, Outpatient consultations, Advanced surgical procedures, Diagnostic services, Emergency and critical care
Stock Listing: NSE (KIMS), BSE (543308)
Promoter: Dr. Bhaskara Rao Bollineni & Family
KIMS's journey began in 1982 when Dr. Bhaskara Rao Bollineni established the first KIMS hospital in Nellore. The company, Krishna Institute of Medical Sciences Limited, was formally incorporated in 2000. Over the years, KIMS expanded its footprint through organic growth and strategic acquisitions, becoming a leading healthcare provider in Andhra Pradesh and Telangana. It successfully completed its Initial Public Offering (IPO) and listed on Indian stock exchanges in 2021, further solidifying its market position as a prominent multi-specialty hospital chain.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Hospital Services | Approximately 99.8% | Majority of EBITDA |
Hospital Services: Encompasses a full spectrum of medical services across various specialties like cardiology, oncology, neurosciences, orthopedics, gastroenterology, renal sciences, and organ transplantation. This includes inpatient and outpatient care, diagnostic facilities, surgical interventions, and emergency services.
Clinical Expertise & Infrastructure: Operates a network of multi-specialty hospitals equipped with advanced medical technology, state-of-the-art infrastructure, and a team of highly qualified doctors and medical professionals, ensuring comprehensive patient care.
Dr. Bhaskara Rao Bollineni - Chairman & Managing Director. A visionary healthcare entrepreneur and cardiac surgeon with over four decades of experience, he is the founder of KIMS Hospitals. Dr. Abhinay Bollineni - Executive Director & CEO. He holds an MBA from Cornell University and has been instrumental in the company's growth and operational excellence since joining KIMS.
KIMS Hospital Ongole Private Limited
KIMS Hospital Srikakulam Private Limited
KIMS Hospital Vizianagaram Private Limited
KIMS Hospital Anantapur Private Limited
Sunshine Hospitals Hyderabad Private Limited (acquired 2022)
KIMS Hospital Mahabubnagar Private Limited
Acquisition of Sunshine Hospitals Private Limited in Q1 FY23 for ₹737 crore, significantly expanding its presence in Telangana and enhancing bed capacity. Initial Public Offering (IPO) in 2021.
The Krishna Institute of Medical Sciences Ltd share price today is ₹758.40 on NSE (KIMS), as of 08 Sept 2026.
As of 01 Sept 2026, Krishna Institute of Medical Sciences Ltd share price is ₹758.40, with previous close ₹758.40. Today's range is ₹758.40 to ₹758.40. The 52-week range is ₹758.40 to ₹758.40.
As of today, Krishna Institute of Medical Sciences Ltd's market cap is ₹29,600.35 crore (Large Cap).
Krishna Institute of Medical Sciences Ltd's current P/E ratio is 116.32, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 48.
Krishna Institute of Medical Sciences Ltd's current P/B ratio is 13.49.
Krishna Institute of Medical Sciences Ltd's current dividend yield is N/A. Last dividend of ₹3.00 per share was declared on 11-Aug-2023.
Krishna Institute of Medical Sciences Ltd's EPS (TTM) is ₹-37.25.
Krishna Institute of Medical Sciences Ltd (KIMS) is one of the largest corporate healthcare groups in South India, operating a chain of multi-specialty hospitals. It provides comprehensive healthcare services, including advanced medical, surgical, and diagnostic treatments, primarily across Andhra Pradesh and Telangana, focusing on affordable quality care and clinical excellence.
Krishna Institute of Medical Sciences Ltd is promoted by Dr. Bhaskara Rao Bollineni & Family, holding 34.11% as of 01 Sept 2026.
Krishna Institute of Medical Sciences Ltd is listed on NSE (KIMS) and BSE (543308). Its next quarterly results are expected on August 2024 (for Q1 FY25 results).